Mark Lee
Senior Vice President, Corporate Management and Communications
Replay available
HUTCHMED (China) Limited (NASDAQ: HCM) Q4 2023 earnings conference call, held 2024-02-28. Replay captured from the company's public earnings webcast.

Senior Vice President, Corporate Management and Communications
Chief Executive Officer and Chief Scientific Officer
Chief Financial Officer
Head of Manufacturing
Head of Late-Stage Pipeline
Analyst, Kent Hall
Analyst, Bank of America
Analyst, Goldman Sachs
Watch the replay and follow the connected company analysis, news, and investor updates for Hutchmed (china) Limited.
WEBVTT 00:00:00.572 -- 00:00:04.253 Good day and thank you for standing by. Welcome to HushMed 2023 00:00:04.253 -- 00:00:07.214 Full-Year Financial Results Conference Call. 00:00:07.214 -- 00:00:10.315 At this time, all participants are in a listen-only mode. 00:00:10.315 -- 00:00:14.576 After the speaker's presentation, there will be a question-and-answer session. 00:00:14.576 -- 00:00:19.158 To ask a question during the session, you need to press star 11 on your telephone. 00:00:19.158 -- 00:00:22.859 You'll then hear an automated message advising your hand is raised. 00:00:22.859 -- 00:00:26.081 Please be advised that today's conference is being recorded. 00:00:26.081 -- 00:00:29.063 I'd now like to pass the call over to your first speaker today, Mr. 00:00:29.063 -- 00:00:33.907 Mark Lee, Senior Vice President, Corporate Management and Communications of Hachmed. 00:00:33.907 -- 00:00:36.569 Thank you. Please go ahead. 00:00:36.569 -- 00:00:41.492 Thank you, Desmond. Welcome, everybody. Good morning, good afternoon, good evening. 00:00:41.492 -- 00:00:46.816 Just a brief message as usual. The performance results and operations of Hachmed 00:00:46.816 -- 00:00:51.799 are historic in nature, and past performance is no guarantee of the future. 00:00:51.799 -- 00:00:55.755 We've got forward-looking statements, which means Within the meaning of the safe harbor 00:00:55.755 -- 00:00:59.295 provisions of the U.S. SEC, 00:00:59.436 -- 00:01:04.939 this presentation is for investors only, and information on pharmaceuticals 00:01:04.939 -- 00:01:08.681 are not intended as advertising or medical advice. 00:01:08.681 -- 00:01:13.744 This presentation contains statistical and other third-party data which we 00:01:13.744 -- 00:01:16.225 have not independently verified, 00:01:16...